Faraday Pharmaceuticals Announces First Patient Enrolled in Phase II Study for ICU-Acquired Weakness
Faraday Pharmaceuticals, Inc., a biopharmaceutical company dedicated to improving the quality of life for patients…
dcorriganOctober 19, 2021
Read news stories from Science in Seattle.